VANTAGE HEALTH (OTC:VNTH) has been getting hot and cold over the past days. Yesterday, the stock jumped up again by 
soaring 21.43% on the market, while its trading volume increased. However, the most intriguing fact here is that the price varies on promotions.
The records show that VNTH has been intensively promoted since yesterday and the campaign is still on today. The alerts cost $47.500 by now, paid by HH Group, LLC. Looks like it is just the promotions that have pushed up the stock price again, supported by a piece of news by Vantage Health.
Again yesterday, the company reported that its 51% owned subsidiary, Moxisign, was negotiating a supply agreement with a major pharmaceutical retail group. The contract will cover generic pharmaceutical products and it is expected to run from January 2013. Yet, revenues from this contract will only be generated when MCC approves each drug dossier.
Apparently, the agreement news along with the promotions have immediately pumped up VNTH stock price. However, the company seems convinced to hold the gain for longer, as the campaign continues.[BANNER]
Vantage Health is an importer and distributor of pharmaceutical products and medical consumables to the public and private sectors. According to its latest 10-Q report, the company’s financials are not reliable at all.
As of 31 March, this year liabilities of VNTH are much higher than its total assets, and the stockholders’ deficiency is a negative value. At the same time, the company’s accumulated deficit during the development stage has notably increased, while revenues still total $nil.
As a development stage company, Vantage operates mainly on loans and selling of common stock. However, due to the incurred losses and lack of revenues, the company’s ability to continue remains under a going concern.
